Condition: Breast Cancer · Sponsor: Endomagnetics Ltd.
The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur using patient reported outcome measures.
This description comes directly from the study's public registry record.
Vicky Crawford · +441223652617 · vcrawford@endomag.com
Always discuss trial participation with your own doctor first.
| UNC, Lineberger Comprehensive Cancer Center | Chapel Hill, North Carolina, United States | Recruiting |
| VCU Massey Comprehensive Cancer Center | Richmond, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06610539